Sibeprenlimab( —— )

Catalog No. M36868 CAS No. 2382896-07-1

Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody that inhibits APRIL and may be investigated for the prevention and treatment of kidney disease (IgAN).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	301	Get Quote
5MG	588	Get Quote
10MG	938	Get Quote
25MG	1343	Get Quote
50MG	1812	Get Quote
100MG	2394	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Sibeprenlimab
Note

Research use only, not for human use.
Brief Description

Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody that inhibits APRIL and may be investigated for the prevention and treatment of kidney disease (IgAN).
Description

Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody. Sibeprenlimab can inhibit APRIL. Sibeprenlimab can be used for the research of IgA nephropathy (IgAN).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

2382896-07-1
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Mohit Mathur, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers. Kidney Int Rep. 2022 Feb 8;7(5):993-1003. ?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks